AST's COTS welcomes Drs. Zhanzak, Larsen, Kissick, and Fribourg to discuss how targeting a narrow range of donor antigens may prevent DSA formation and improve transplant outcomes.
"Identification of indirect CD4+ T cell epitopes associated with transplant rejection provides a target for donor-specific tolerance induction"
(Immunity. 2025 Feb 11;58(2):448-464.e6. doi: 10.1016/j.immuni.2025.01.008. Epub 2025 Jan 30.)
In this article:
Antibodies against the donor human leukocyte antigen (HLA) molecules drive late transplant failure, with HLA-DQ donor-specific antibodies (DSAs) posing the highest rejection risk. Here, [the authors] investigated the role of indirect CD4+ T cell epitopes-donor-derived peptides presented by recipient major histocompatibility complex (MHC) class II-in DSA formation. Antigen mapping of samples from HLA-DQ DSA-positive kidney and heart transplant recipients revealed two polymorphic hotspots in donor HLA-DQ that generated alloreactive peptides... Systemic delivery of high-dose donor H2-Kd peptides combined with CTLA4-Ig reduced the frequencies of Kd287+ CD4+ T cells and DSA formation. Thus, targeting a narrow range of donor antigens may prevent DSA formation and improve transplant outcomes. Read more.
Speaker:
Zhuldyz Zhanzak, PhD Candidate • Emory University, Atlanta, GA
Moderator:
Miguel Fribourg, PhD • Icahn School of Medicine at Mount Sinai, New York, NY
Discussants:
This AST Journal Club Series webinar is hosted by AST's Community of Transplant Scientists (COTS). All AST Journal Clubs are free but registration is required to attend live.